TL;DR

Key Facts

What Are White Lesions?

A white appearance in the oral mucosa results from one of three mechanisms: thickening of the keratin layer (hyperkeratosis or parakeratosis), which scatters light back as white; accumulation of surface debris (fungal pseudomembranes, food, desquamated cells); or intracellular oedema of the spinous layer (as in leukoedema), which causes a diffuse milky opacity. Understanding the mechanism helps predict whether the lesion will wipe off and informs the biopsy strategy.

White lesions are among the most common presentations in oral medicine clinics. The clinical imperative is to identify the approximately 5–10% that represent potentially malignant disorders — principally leukoplakia with dysplasia and erosive lichen planus — while efficiently managing the majority that are benign and reactive. Age, site, tobacco and alcohol use, candidal status, systemic health, and the presence of dysplastic features on biopsy are the principal risk-stratification tools.

The Wipe Test: The First Diagnostic Step

The wipe test is performed by gently rubbing the white lesion with dry gauze or a wooden spatula. A lesion that wipes off — leaving a raw, erythematous, or bleeding base — consists of loose surface material (most commonly fungal pseudomembrane) and is not a true keratosis. A lesion that cannot be wiped off is adherent to the mucosa and represents epithelial change (keratosis, dysplasia, lichenoid reaction, or structural abnormality).

Lesions That Cannot Be Wiped Off

Leukoplakia

The WHO defines leukoplakia as “a white plaque of questionable risk having excluded (other) known diseases or disorders” — it is explicitly a diagnosis of exclusion. A white patch can only be called leukoplakia once all other possible causes (friction, candida, lichen planus, chemical trauma, white sponge naevus, etc.) have been excluded. It is the most common potentially malignant disorder of the oral cavity, with a prevalence of approximately 2% in the general population and a strong association with tobacco and alcohol use.

Leukoplakia is classified by morphology into homogeneous (uniformly flat, thin, white; low risk) and non-homogeneous subtypes — the latter including speckled leukoplakia (erythroleukoplakia: white patches on red background), nodular/granular, and verrucous forms. Non-homogeneous leukoplakia carries a substantially higher risk of dysplasia and malignant transformation. Proliferative verrucous leukoplakia (PVL) is a particularly aggressive multifocal, progressive subtype with a high rate of malignant transformation (~70%) predominantly in elderly women with no history of tobacco use.

High-risk sites are the floor of mouth, ventral tongue, and soft palate complex. Biopsy is essential for all leukoplakias; histology reporting of dysplasia (mild, moderate, severe) drives management. Mild dysplasia: removal of aetiological factor and surveillance. Moderate-severe dysplasia: excision or laser ablation. Carcinoma in situ and invasive SCC require oncological management.

Oral Lichen Planus (OLP)

Oral lichen planus is a chronic, T-cell-mediated immunological condition affecting approximately 1–2% of the population, with a female predilection (2:1) and peak incidence in the 4th–6th decades. The pathogenesis involves CD8+ T-cell-mediated destruction of basal keratinocytes, triggered by an antigen that may be endogenous (altered self-antigen) or exogenous (drug, dental material, HCV infection). Histology shows a dense, band-like subepithelial lymphocytic infiltrate, liquefaction degeneration of the basal cell layer, and saw-tooth rete ridges. Colloid (Civatte) bodies — apoptotic keratinocytes — are present at the epithelial–connective tissue interface.

OLP presents in six clinical forms: reticular (most common — interlacing white striae called Wickham’s striae, typically on buccal mucosa), papular, plaque-like, atrophic/erythematous, erosive (painful, raw areas with peripheral striae), and bullous. The buccal mucosa bilaterally is the most frequent site, though gingiva, tongue, lips, and palate can be involved. Desquamative gingivitis is a common gingival presentation.

OLP has a malignant transformation rate of 0.5–3%, predominantly from the erosive and atrophic variants. The WHO classifies it as a potentially malignant disorder requiring long-term surveillance (6-monthly). Treatment is with topical corticosteroids (clobetasol, fluocinolone); systemic immunosuppression for refractory cases. Tacrolimus 0.1% is an effective steroid-sparing topical agent.

Lichenoid Reactions

Lichenoid reactions are histologically and often clinically indistinguishable from OLP but have an identifiable cause: a dental restorative material in direct contact with the mucosa (most commonly amalgam or gold), or a systemic drug (NSAIDs, ACE inhibitors, antimalarials, beta-blockers, oral hypoglycaemics). They resolve on removal of the causative agent, distinguishing them from true OLP. Patch testing may identify relevant dental material allergens. Drug-induced lichenoid reactions resolve over weeks to months after drug cessation.

Leukoedema

Leukoedema is an extremely common, completely benign mucosal condition caused by intracellular oedema of the spinous layer producing a diffuse, milky, grey-white, translucent opalescence — most prominent on the buccal mucosa bilaterally. The key feature is that stretching the mucosa makes the white appearance disappear — this is pathognomonic and distinguishes leukoedema from all other white lesions. It is more prevalent and more pronounced in individuals of African and Asian descent and requires no treatment or follow-up.

White Sponge Naevus

White sponge naevus is an autosomal dominant condition caused by mutations in keratin 4 or keratin 13, producing a diffuse, bilateral, spongy, folded white appearance of the buccal mucosa from early childhood. The lesions are symmetric and extensive but entirely benign. Other mucous membranes (oesophageal, nasal, vaginal, rectal) may be similarly affected. No treatment is required, though tetracycline mouth rinses may reduce the thickness of the keratotic layer. The diagnosis is important to make to avoid unnecessary biopsy and patient anxiety.

Oral Hairy Leukoplakia

Oral hairy leukoplakia (OHL) is caused by Epstein-Barr virus (EBV) replicating in superficial epithelial cells in immunocompromised individuals — most commonly in HIV-positive patients but also in transplant recipients and other immunosuppressed states. It presents as white, vertically corrugated (“hairy”) patches on the lateral borders of the tongue, usually bilateral. The surface cannot be wiped off and the corrugations run vertically along the length of the tongue margin.

OHL has no malignant potential and does not require treatment in its own right. Its clinical significance is as a marker of significant immunosuppression — its presence in an HIV-positive patient indicates a CD4 count typically below 300 cells/µL and warrants assessment for initiation or optimisation of antiretroviral therapy. The lesion usually resolves with effective ART.

Chemical Burns (Aspirin Burn)

Topical application of aspirin or other caustic agents directly to the oral mucosa produces a white, necrotic, sloughing plaque that may resemble a pseudomembranous candida lesion. The history is diagnostic — patients typically describe placing an aspirin tablet against a painful tooth. The slough wipes off leaving an ulcerated, painful base. Management is symptomatic; the burn heals within 1–2 weeks once the causative agent is removed.

Lesions That Can Be Wiped Off

Pseudomembranous Candidiasis (Oral Thrush)

Pseudomembranous candidiasis is caused by Candida albicans (occasionally other Candida species) overgrowing the oral mucosa, typically in the context of a predisposing factor that disrupts the normal host-pathogen balance. The classic presentation is creamy-white, curd-like plaques that wipe off with gauze, leaving a raw, erythematous, sometimes bleeding base.

Predisposing factors can be summarised as local or systemic. Local: dry mouth (xerostomia), denture wearing (especially overnight), inhaled corticosteroid use, broad-spectrum antibiotic therapy, recent radiotherapy to the head and neck. Systemic: diabetes mellitus, immunosuppression (HIV, leukaemia, systemic corticosteroids, organ transplant), nutritional deficiency (iron, B12, folate), extremes of age. Identifying and correcting the predisposing factor is as important as the antifungal prescription itself.

Treatment: oral nystatin suspension or pastilles; fluconazole 50 mg daily for 7 days for moderate-severe or resistant cases. Dentures must be simultaneously treated (soaked in 0.2% chlorhexidine or antifungal solution overnight) and patients instructed not to wear them at night. Recurrent or refractory candidiasis warrants investigation for undiagnosed HIV or diabetes.

Malignant Transformation Risk

Stratifying white lesions by malignant transformation risk is the core clinical skill in this area. The following hierarchy, based on site, morphology, and histology, guides follow-up intensity and the threshold for treatment.

White Lesions at a Glance

Clinical Considerations

• Tobacco cessation is the single most important intervention for leukoplakia: Approximately 50% of leukoplakias regress or disappear with tobacco cessation alone. Cessation should be strongly advocated before and after any surgical intervention, and the lesion should be reassessed 6–8 weeks after cessation prior to biopsy if the diagnosis is uncertain.
• The floor of mouth and ventral tongue are the highest-risk sites: These sites are bathed in pooled saliva concentrating dissolved carcinogens from tobacco and alcohol. Leukoplakias in these locations should be biopsied without delay and followed intensively regardless of histological grading.
• OLP requires lifelong monitoring: The erosive and atrophic variants carry meaningful malignant transformation risk. Patients with OLP should be reviewed at minimum every 6 months and any new or changing areas within established OLP require biopsy. Steroid therapy should be discontinued if early malignant change is detected.
• Always treat candida before biopsying a white lesion if there is clinical doubt: A two-week antifungal trial is appropriate when the clinical picture is consistent with candidiasis. However, if the lesion does not resolve completely, biopsy is mandatory — candidiasis can colonise a dysplastic or malignant lesion and give a falsely reassuring clinical picture.
• Hairy leukoplakia should trigger HIV testing: In a patient not known to be HIV-positive, oral hairy leukoplakia warrants HIV serology as part of the investigation. In HIV-positive patients, its presence indicates a low CD4 count and should prompt review of ART adherence and effectiveness.

Common Mistakes & Misconceptions

• Misconception: “Leukoplakia means cancer.”
  Correction: Leukoplakia is a clinical term for a white patch — not a diagnosis of cancer. Most leukoplakias (approximately 80%) show no dysplasia on biopsy and remain benign. Malignant transformation occurs in 1–17% over many years depending on subtype and site. The risk is real but the majority of lesions never transform.
• Misconception: “Oral lichen planus only presents as white striae.”
  Correction: OLP has six clinical forms. The erosive and atrophic variants present as raw, painful mucosal areas with peripheral striae that may be subtle. These variants are the ones with meaningful malignant potential and are commonly underdiagnosed because the white component is inconspicuous.
• Misconception: “Leukoedema should be biopsied to exclude leukoplakia.”
  Correction: Leukoedema has a pathognomonic sign — the opalescence disappears when the mucosa is stretched. If this sign is present, the diagnosis is secure and biopsy is unnecessary and inappropriate. Performing needless biopsies on benign conditions causes harm and erodes patient trust.
• Misconception: “Hairy leukoplakia can undergo malignant transformation.”
  Correction: Hairy leukoplakia is EBV-driven and has no malignant potential. It is clinically significant purely as a marker of immunosuppression. Confusing it with leukoplakia (a potentially malignant disorder) leads to unnecessary intervention.
• Misconception: “A white lesion in a non-smoker is unlikely to be dysplastic.”
  Correction: Proliferative verrucous leukoplakia — the most aggressive leukoplakia subtype — predominantly affects elderly women with no history of tobacco use. Any unexplained white lesion in a non-smoker, particularly if multifocal or verrucous, requires biopsy without delay.

Related Topics

White lesions interconnect with several major areas of oral medicine and pathology.

References & Sources

1. Warnakulasuriya S, Johnson NW, van der Waal I (2007). “Nomenclature and classification of potentially malignant disorders of the oral mucosa.” Journal of Oral Pathology & Medicine, 36(10):575–580.
2. Neville BW, Damm DD, Allen CM, Chi AC (2015). Oral and Maxillofacial Pathology, 4th ed. Elsevier Saunders.
3. van der Waal I (2009). “Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management.” Oral Oncology, 45(4–5):317–323.
4. Scully C, Carrozzo M (2008). “Oral mucosal disease: lichen planus.” British Journal of Oral and Maxillofacial Surgery, 46(1):15–21.
5. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I (1997). World Health Organization: Histological Typing of Cancer and Precancer of the Oral Mucosa. Springer.
6. Regezi JA, Sciubba JJ, Jordan RCK (2017). Oral Pathology: Clinical Pathologic Correlations, 7th ed. Elsevier.

Summary

White lesions of the oral cavity form one of the most clinically important and practically challenging areas in dental and oral medicine practice. The wipe test is the essential first step, separating surface accumulations (candida) from epithelial keratosis. Among the keratotic lesions, the priority is to identify potentially malignant disorders — leukoplakia and erosive lichen planus — and stratify their risk by site, morphology, and histology. Benign conditions such as leukoedema, white sponge naevus, and hairy leukoplakia must be recognised to avoid unnecessary biopsies. Every clinician should apply the 2-to-3-week biopsy rule: any unexplained white lesion that persists after removal of the apparent cause requires histological diagnosis.

About the Author

Dr. Andries Smith

Founder, Dental Panda

Dr. Andries Smith founded Dental Panda in 2020. As an immigrant to the United States, he had to take the INBDE exam, even though he was practicing dentistry for over 10 years. This revealed an opportunity. Andries noticed that INBDE prep course companies were putting profit over students. With his expertise and experience in dentistry, he created free dental wiki resources for students and the general public to have access to.